| Literature DB >> 36073784 |
James P Bridges1, Caterina Safina2, Bernard Pirard2, Kari Brown1, Alyssa Filuta1, Ravichandran Panchanathan3, Rochdi Bouhelal2, Nicole Reymann2, Sejal Patel4, Klaus Seuwen2, William E Miller3, Marie-Gabrielle Ludwig2.
Abstract
The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 have not been completely deciphered. We set out to investigate the physiological importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor activation. To examine this hypothesis, we characterized tethered agonist-mediated activation of GPR116 in vitro and in vivo. A knock-in mouse expressing a non-cleavable GPR116 mutant phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor activation is indispensable for function in vivo. Using site-directed mutagenesis and species-swapping approaches, we identified key conserved amino acids for GPR116 activation in the tethered agonist sequence and in extracellular loops 2/3 (ECL2/3). We further highlight residues in transmembrane 7 (TM7) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model supporting tethered agonist:ECL2 interactions for GPR116 activation.Entities:
Keywords: adhesion GPCR ADGRF5; autocatalytic GPS cleavage; cell biology; human; modeling; mouse; pulmonary surfactant; tethered agonist activation
Mesh:
Substances:
Year: 2022 PMID: 36073784 PMCID: PMC9489211 DOI: 10.7554/eLife.69061
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.713